182 related articles for article (PubMed ID: 21825980)
1. Cytochrome P450-dependent eicosanoid production and crosstalk.
Fleming I
Curr Opin Lipidol; 2011 Oct; 22(5):403-9. PubMed ID: 21825980
[TBL] [Abstract][Full Text] [Related]
2. The cytochrome P450 pathway in angiogenesis and endothelial cell biology.
Fleming I
Cancer Metastasis Rev; 2011 Dec; 30(3-4):541-55. PubMed ID: 22009065
[TBL] [Abstract][Full Text] [Related]
3. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
Fleming I
Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
[TBL] [Abstract][Full Text] [Related]
4. Epoxyeicosatrienoic acid pathway in human health and diseases.
Bellien J; Joannides R
J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
[TBL] [Abstract][Full Text] [Related]
5. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
6. The pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular disease.
Fleming I
Pharmacol Rev; 2014 Oct; 66(4):1106-40. PubMed ID: 25244930
[TBL] [Abstract][Full Text] [Related]
7. The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.
Fleming I
Vascul Pharmacol; 2016 Nov; 86():31-40. PubMed ID: 26975734
[TBL] [Abstract][Full Text] [Related]
8. Lipid mediators generated by the cytochrome P450-Epoxide hydrolase pathway.
Frömel T; Hu J; Fleming I
Adv Pharmacol; 2023; 97():327-373. PubMed ID: 37236763
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.
Imig JD
Cardiovasc Drug Rev; 2006; 24(2):169-88. PubMed ID: 16961727
[TBL] [Abstract][Full Text] [Related]
10. [Soluble epoxide hydrolase and lipid metabolism].
Ma XX; Liu Y; Zhu Y
Sheng Li Ke Xue Jin Zhan; 2010 Aug; 41(4):267-71. PubMed ID: 21416942
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
[TBL] [Abstract][Full Text] [Related]
12. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.
Zordoky BN; El-Kadi AO
Pharmacol Ther; 2010 Mar; 125(3):446-63. PubMed ID: 20093140
[TBL] [Abstract][Full Text] [Related]
13. The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases.
Xu X; Li R; Chen G; Hoopes SL; Zeldin DC; Wang DW
Adv Nutr; 2016 Nov; 7(6):1122-1128. PubMed ID: 28140329
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 Eicosanoid Signaling Pathway in Colorectal Tumorigenesis.
Wang W; Sanidad KZ; Zhang G
Adv Exp Med Biol; 2019; 1161():115-123. PubMed ID: 31562626
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome p450-dependent lipid metabolism in preovulatory follicles.
Newman JW; Stok JE; Vidal JD; Corbin CJ; Huang Q; Hammock BD; Conley AJ
Endocrinology; 2004 Nov; 145(11):5097-105. PubMed ID: 15308618
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: role for omega-3 epoxides.
López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Hwang SH; Titos E; Lopategi A; Hammock BD; Arroyo V; Clària J
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):536-41. PubMed ID: 25550510
[TBL] [Abstract][Full Text] [Related]
17. Soluble Epoxide Hydrolase as a Potential Key Factor for Human Prenatal Development.
Cizkova K; Rajdova A; Ehrmann J
Cells Tissues Organs; 2016; 201(4):277-86. PubMed ID: 27144772
[TBL] [Abstract][Full Text] [Related]
18. Epoxide hydrolases in the rat epididymis: possible roles in xenobiotic and endogenous fatty acid metabolism.
DuTeaux SB; Newman JW; Morisseau C; Fairbairn EA; Jelks K; Hammock BD; Miller MG
Toxicol Sci; 2004 Apr; 78(2):187-95. PubMed ID: 14737000
[TBL] [Abstract][Full Text] [Related]
19. Vascular cytochrome p450 enzymes: physiology and pathophysiology.
Fleming I
Trends Cardiovasc Med; 2008 Jan; 18(1):20-5. PubMed ID: 18206805
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of the soluble epoxide hydrolase-from mouse to man.
Revermann M
Curr Opin Pharmacol; 2010 Apr; 10(2):173-8. PubMed ID: 20079692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
